Skip to main content
NCBI home page
Gut logoLink to Gut
. 1999 Dec;45(6):895–899. doi: 10.1136/gut.45.6.895

Serum interleukin 10 and interleukin 11 in patients with acute pancreatitis

C Chen 1, S Wang 1, R Lu 1, F Chang 1, S Lee 1
PMCID: PMC1727757  PMID: 10562589

Abstract

BACKGROUND—Proinflammatory and anti-inflammatory cytokines are involved in the pathogenesis of acute pancreatitis.
AIMS—To measure the serial serum levels of interleukin 10 and interleukin 11 in patients with acute pancreatitis and analyse the relation of these anti-inflammatory cytokines to disease severity.
METHODS—In 50 patients with acute pancreatitis, the serum concentrations of interleukin 10 and interleukin 11 were determined on days one, two, three, four, and seven after admission. Serum C reactive protein levels were evaluated on days one and two. Severity of pancreatitis was determined according to the Atlanta criteria.
RESULTS—Serum concentrations of interleukin 10 on days one to seven were significantly higher in patients with severe pancreatitis than in those with mild pancreatitis. Patients with severe attacks had significantly elevated serum interleukin 11 concentrations on days two to four compared with those with mild attacks, but not on days one and seven. With cut off levels of 30 pg/ml for interleukin 10, 10.5 pg/ml for interleukin 11, and 115 mg/l for C reactive protein, the accuracy rates for detecting severe pancreatitis were 84%, 64%, and 78% respectively on day one and 82%, 74%, and 84% respectively on day two.
CONCLUSIONS—Serum interleukin 10 and interleukin 11 concentrations reflect the severity of acute pancreatitis. Interleukin 10 is a useful variable for early prediction of the prognosis of acute pancreatitis.


Keywords: acute pancreatitis; C reactive protein; interleukin 10; interleukin 11

Full Text

The Full Text of this article is available as a PDF (108.0 KB).

Figure 1  .

Figure 1  

Open in a new tab

Scatter diagram of serum interleukin 10 in patients with severe or mild pancreatitis on days one and two.

Figure 2  .

Figure 2  

Open in a new tab

Scatter diagram of serum interleukin 11 in patients with severe or mild pancreatitis on days one and two.

Figure 3  .

Figure 3  

Open in a new tab

Serial concentrations of serum interleukin 10 in patients with severe or mild pancreatitis within one week of admission. Data are expressed as mean (SEM). *p<0.05, †p<0.005, ‡p<0.0001 v mild pancreatitis.

Figure 4  .

Figure 4  

Open in a new tab

Serial concentrations of serum interleukin 11 in patients with severe or mild pancreatitis within one week of admission. Data are expressed as mean (SEM). †p<0.005, *p<0.05 v mild pancreatitis.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baumann H., Schendel P. Interleukin-11 regulates the hepatic expression of the same plasma protein genes as interleukin-6. J Biol Chem. 1991 Oct 25;266(30):20424–20427. [PubMed] [Google Scholar]
  2. Bone R. C., Balk R. A., Cerra F. B., Dellinger R. P., Fein A. M., Knaus W. A., Schein R. M., Sibbald W. J. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992 Jun;101(6):1644–1655. doi: 10.1378/chest.101.6.1644. [DOI] [PubMed] [Google Scholar]
  3. Bradley E. L., 3rd A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg. 1993 May;128(5):586–590. doi: 10.1001/archsurg.1993.01420170122019. [DOI] [PubMed] [Google Scholar]
  4. Castell J. V., Gómez-Lechón M. J., David M., Andus T., Geiger T., Trullenque R., Fabra R., Heinrich P. C. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett. 1989 Jan 2;242(2):237–239. doi: 10.1016/0014-5793(89)80476-4. [DOI] [PubMed] [Google Scholar]
  5. Chen C. C., Wang S. S., Lee F. Y., Chang F. Y., Lee S. D. Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis. Am J Gastroenterol. 1999 Jan;94(1):213–218. doi: 10.1111/j.1572-0241.1999.00709.x. [DOI] [PubMed] [Google Scholar]
  6. Exley A. R., Leese T., Holliday M. P., Swann R. A., Cohen J. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut. 1992 Aug;33(8):1126–1128. doi: 10.1136/gut.33.8.1126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fiorentino D. F., Zlotnik A., Mosmann T. R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol. 1991 Dec 1;147(11):3815–3822. [PubMed] [Google Scholar]
  8. Gabay C., Singwe M., Genin B., Meyer O., Mentha G., LeCoultre C., Vischer T., Guerne P. A. Circulating levels of IL-11 and leukaemia inhibitory factor (LIF) do not significantly participate in the production of acute-phase proteins by the liver. Clin Exp Immunol. 1996 Aug;105(2):260–265. doi: 10.1046/j.1365-2249.1996.d01-757.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gross V., Andreesen R., Leser H. G., Ceska M., Liehl E., Lausen M., Farthmann E. H., Schölmerich J. Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest. 1992 Mar;22(3):200–203. doi: 10.1111/j.1365-2362.1992.tb01826.x. [DOI] [PubMed] [Google Scholar]
  10. Gross V., Leser H. G., Heinisch A., Schölmerich J. Inflammatory mediators and cytokines--new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterology. 1993 Dec;40(6):522–530. [PubMed] [Google Scholar]
  11. Hanley J. A., McNeil B. J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982 Apr;143(1):29–36. doi: 10.1148/radiology.143.1.7063747. [DOI] [PubMed] [Google Scholar]
  12. Harmoinen A., Perko M., Grönroos P. Rapid quantitative determination of C-reactive protein using LKB 8600 Reaction Rate Analyser. Clin Chim Acta. 1981 Mar 19;111(1):117–120. doi: 10.1016/0009-8981(81)90430-7. [DOI] [PubMed] [Google Scholar]
  13. Heath D. I., Cruickshank A., Gudgeon M., Jehanli A., Shenkin A., Imrie C. W. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut. 1993 Jan;34(1):41–45. doi: 10.1136/gut.34.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Larvin M., McMahon M. J. APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet. 1989 Jul 22;2(8656):201–205. doi: 10.1016/s0140-6736(89)90381-4. [DOI] [PubMed] [Google Scholar]
  15. Leser H. G., Gross V., Scheibenbogen C., Heinisch A., Salm R., Lausen M., Rückauer K., Andreesen R., Farthmann E. H., Schölmerich J. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology. 1991 Sep;101(3):782–785. doi: 10.1016/0016-5085(91)90539-w. [DOI] [PubMed] [Google Scholar]
  16. Marchant A., Devière J., Byl B., De Groote D., Vincent J. L., Goldman M. Interleukin-10 production during septicaemia. Lancet. 1994 Mar 19;343(8899):707–708. doi: 10.1016/s0140-6736(94)91584-9. [DOI] [PubMed] [Google Scholar]
  17. Molloy R. G., Mannick J. A., Rodrick M. L. Cytokines, sepsis and immunomodulation. Br J Surg. 1993 Mar;80(3):289–297. doi: 10.1002/bjs.1800800308. [DOI] [PubMed] [Google Scholar]
  18. Neben S., Turner K. The biology of interleukin 11. Stem Cells. 1993 Jul;11 (Suppl 2):156–162. doi: 10.1002/stem.5530110825. [DOI] [PubMed] [Google Scholar]
  19. Oezcueruemez-Porsch M., Kunz D., Hardt P. D., Fadgyas T., Kress O., Schulz H. U., Schnell-Kretschmer H., Temme H., Westphal S., Luley C. Diagnostic relevance of interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis. Dig Dis Sci. 1998 Aug;43(8):1763–1769. doi: 10.1023/a:1018887704337. [DOI] [PubMed] [Google Scholar]
  20. Pezzilli R., Billi P., Miniero R., Barakat B. Serum interleukin-10 in human acute pancreatitis. Dig Dis Sci. 1997 Jul;42(7):1469–1472. doi: 10.1023/a:1018814710291. [DOI] [PubMed] [Google Scholar]
  21. Ralph P., Nakoinz I., Sampson-Johannes A., Fong S., Lowe D., Min H. Y., Lin L. IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol. 1992 Feb 1;148(3):808–814. [PubMed] [Google Scholar]
  22. Ransohoff D. F., Feinstein A. R. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med. 1978 Oct 26;299(17):926–930. doi: 10.1056/NEJM197810262991705. [DOI] [PubMed] [Google Scholar]
  23. Ranson J. H., Pasternack B. S. Statistical methods for quantifying the severity of clinical acute pancreatitis. J Surg Res. 1977 Feb;22(2):79–91. doi: 10.1016/0022-4804(77)90045-2. [DOI] [PubMed] [Google Scholar]
  24. Rinderknecht H. Fatal pancreatitis, a consequence of excessive leukocyte stimulation? Int J Pancreatol. 1988 Mar;3(2-3):105–112. doi: 10.1007/BF02798921. [DOI] [PubMed] [Google Scholar]
  25. Rongione A. J., Kusske A. M., Kwan K., Ashley S. W., Reber H. A., McFadden D. W. Interleukin 10 reduces the severity of acute pancreatitis in rats. Gastroenterology. 1997 Mar;112(3):960–967. doi: 10.1053/gast.1997.v112.pm9041259. [DOI] [PubMed] [Google Scholar]
  26. Taga K., Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol. 1992 Feb 15;148(4):1143–1148. [PubMed] [Google Scholar]
  27. Trepicchio W. L., Bozza M., Pedneault G., Dorner A. J. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J Immunol. 1996 Oct 15;157(8):3627–3634. [PubMed] [Google Scholar]
  28. Van Laethem J. L., Eskinazi R., Louis H., Rickaert F., Robberecht P., Devière J. Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut. 1998 Sep;43(3):408–413. doi: 10.1136/gut.43.3.408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Van Laethem J. L., Marchant A., Delvaux A., Goldman M., Robberecht P., Velu T., Devière J. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology. 1995 Jun;108(6):1917–1922. doi: 10.1016/0016-5085(95)90158-2. [DOI] [PubMed] [Google Scholar]
  30. Viedma J. A., Pérez-Mateo M., Domínguez J. E., Carballo F. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut. 1992 Sep;33(9):1264–1267. doi: 10.1136/gut.33.9.1264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Willems F., Marchant A., Delville J. P., Gérard C., Delvaux A., Velu T., de Boer M., Goldman M. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol. 1994 Apr;24(4):1007–1009. doi: 10.1002/eji.1830240435. [DOI] [PubMed] [Google Scholar]
  32. Wilson C., Heath D. I., Imrie C. W. Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg. 1990 Nov;77(11):1260–1264. doi: 10.1002/bjs.1800771120. [DOI] [PubMed] [Google Scholar]
  33. Yin T. G., Schendel P., Yang Y. C. Enhancement of in vitro and in vivo antigen-specific antibody responses by interleukin 11. J Exp Med. 1992 Jan 1;175(1):211–216. doi: 10.1084/jem.175.1.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. van Deuren M., van der Ven-Jongekrijg J., Bartelink A. K., van Dalen R., Sauerwein R. W., van der Meer J. W. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J Infect Dis. 1995 Aug;172(2):433–439. doi: 10.1093/infdis/172.2.433. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES